Neuromodulation Market Growing at 11.2% CAGR to 2020
PUNE, India, April 28, 2016 /PRNewswire/ --
Global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020 and reach $6.20 Billion by 2020 driven by factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players.
Complete report on global neuromodulation market spread across 182 pages, profiling 10 companies and supported with 84 tables and 32 figures is now available at http://www.reportsnreports.com/reports/214982-neuromodulation-market-spinal-cord-stimulation-scs-vagus-nerve-stimulation-vns-gastric-electrical-stimulation-ges-deep-brain-stimulation-dbs-sacral-nerve-stimulation-sns-transcranial-magnetic-stimulation-tms-forecasts-to-2017.html .
Over the years, the global healthcare industry has witnessed a paradigm shift, and is now increasingly focused on minimally invasive therapies that not only treats a wide range of chronic and refractory disorders but also have fewer side effects. The demand for neuromodulation has increased significantly, because of patients' preference for minimally invasive surgeries. Moreover, these therapies are reversible, which allows physicians to cease treatment, as and when required by removing the stimulating devices.
Based on technology, the internal neuromodulation segment is expected to be the largest and fastest-growing component segment in 2015. In internal neuromodulation category, spinal cord stimulation segment is expected to dominate the neuromodulation market in 2015. However, the deep brain stimulation segment is expected to grow at the highest CAGR from 2015 to 2020. In the external neuromodulation category, the transcutaneous electrical nerve stimulation segment is expected to be the largest segment in the neuromodulation market. However, the transcranial magnetic stimulation segment has registered the highest CAGR during the forecast period.
North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of equipment and devices involved in neuromodulation.
Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel). Order a copy of Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020 research report at http://www.reportsnreports.com/purchase.aspx?name=214982 .
The global neuromodulation market witnesses high-competitive intensity as there are several big and small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, mergers, collaborations, acquisitions, new product launches, market development, geographical expansions, and acquisitions) to increase their market shares and establish a strong foothold in the global neuromodulation market.
On a related note, another research on Digital PCR (dPCR) and qPCR Market Global Forecasts to 2021 says, the global market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. The research is segmented on the basis of technology, products and services, applications, and end users. Geographically, North America is expected to account for the largest share of the global qPCR and dPCR market in 2016, followed by Europe. Companies like Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V. and Agilent Technologies, Inc. have been profiled in this 177 pages research report available at http://www.reportsnreports.com/reports/344433-digital-pcr-dpcr-and-qpcr-market-by-technology-product-instruments-reagents-software-end-user-research-lab-academia-hospitals-pharmaceutical-biotechnology-cos-cros-application-research-diagnostic-forensic-global-forecast-to-2019.html .
Explore more reports on the Biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/.
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn: https://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
[email protected]
SOURCE ReportsnReports
Share this article